Inflammatory response - vascular
Transient vasoconstriction
-> Vasodilatation
- arterioles first, induced by histamine and NO, so ↑ blood flow and ↑ hydrostatic pressure
-> ↑ vascular permeability
- phase 1 - immediate transient response, mediated by histamine, leukotrienes, neuropeptide susbtance P, bradykinin, short lived (<30mins) and reversible
- phase 2 - prolonged response after direct endothelial injury affecting all levels of microcirculation
-> Exudation
- inflammatory extravascular fluid with high protein concentration and specific gravity >1.02
- ↓ intravascular osmotic pressure and ↑interstital osmotic pressure, oedema
-> increased blood viscosity
-> blood stasis
-> margination of leucocytes
Inflammatory response - cellular
Leukocyte extravasation
- margination
-> leukocyte adhesion to endothelium (regulated by endothelial binding receptors eg selectins, immunoglobulins, integrins, mucin-like glycoproteins)
-> leukocyte diapedesis (process of transmigration across endothelium, mainly in venules)
-> chemotaxis (elicited by exogeneous agents eg bacteria, and endogenous agents eg components of complement systems, leukotriene, cytokines)
Phagocytosis
- micobicidal substnaces released into extracellular space and phagolysosomes during phagocytosis by leukocytes
- eg lysosymal enxymes, reactive oxygen intermediates (H2O2), products of arachidonic acid metabolism (leukotrienes and prostaglandins)
- can cause endothelial and tissue damage including acute respiratory distress syndrome, acute transplant rejection, asthma, reperfusion injury
Chemical mediators of inflammation
MAIN ACUTE PHASE RESPONSE INDUCED BY TNF AND IL1
Haemogen factor activation - aka factor 12, from liver and plasma, works to activate kinin, clotting, fibrinolytic and complement systems
Complement system - from liver and plasma
Cytokines and NO - from endothelium and macrophages
Platelet activating factor - from endothelium and leukocytes
Serotonin - from platelets and mast cells, to increase vascular permeability
Histamine - from platelets and mast cells, assoc with IgE
Bradykinin - to increase vascular permeability, vasodilation, smooth muscle contraction, chemotaxis, activates Hageman factor. Formed by kallikrein, inactivated by ACE in lungs (protected by ACEi)
+ Prostaglandins, leukotrienes, platelet-activating factor, lysosomal enzymes
Signs of inflammation
Raised ESR (due to RBC clumping)
Leucocytosis - increased no of immature neutrophils
4 cardinal signs - rubour (red), calor (heat), dolor (pain), tumour (swelling)
Virchow sign = loss of function
Acute inflammation
Rapid onset and short duration
VASCULAR/CELLULAR CHANGES
- initial vasoconstriction then vasodilation, slowing of circulation (stasis), margination of leukocytes, central sludging of RBCs
- increased vascular permeability
- exudation of fluid - serous, fibrinous, purulent
- emigration of leukocytes (mostly neutrophils)
-> complete resolution / fibrosis / abscess / chronic inflammation
Chronic inflammation
From persistent infection, prolonged exposure to foreign agents, or autoimmune
Can start de novo without acute inflammation
Characterised by - infiltration by macrophages, tissue destruction, attempted repair by proliferation of new blood vessels, and fibrosis
Granulomatous inflammation
Pattern of chronic inflammation characterised by granulomas (focal) and epitheloid cells (activated macrophages) surrounded by mononuclear leukocytes
All can contain giant cells
TB - caseating granuloma, Langhans giant cell, mantoux test
Cat-scratch disease - stellate granuloma, contains neutrophils
Sarcoidosis - non-caseating granuloma, Schaumann’s body, raised ACE levels, Kveim’s test
Cellular adaptation
= cellular changes occuring in response to persistent physiological or pathological stress
ATROPHY - ↓cell size
- due to ↓ workload, loss of innervation/blood supply, inadequate nutrition, loss of endocrine stimulation, pressure
HYPERTROPHY - ↑cell size
HYPERPLASIA - ↑number of cells
- from increased cell mitosis, physiological (hormonal or compensatory) or pathological eg endometriosis
METAPLASIA - cell type replaced by another cell type, reversible but if stimuli persist then can -> cancer
DYSPLASIA - abnormal changes in cell shape and size, aka atypical hyperplasia
Cell injury
When limits of adaptive responses exceeded
Reversible or irreversible
See - ↓oxidative phosphorylation, ↓ATP, cellular swelling (aka hydropic degeneration)
Cell death
From irreversible cell injury
Necrosis = traumatic cell death
Apoptosis = programmed cell death
Autolysis = non-traumatic cell death occurring via action of own enzymes
See - mitochondrial damage, loss of membrane permeability
- pyknosis (condensation of chromatin), karyorrhexis (fragmentation of nuclear material), karyolysis (dissolution of nucleus)
Mechanisms of cell injury
Apoptosis
Programmed cell death
See - intact cell membrane, degradation of nuclear DNA. Cell shrinkage, chromatin condensation, formation of cytoplasmic blebs and apoptotic bodies, phagocytosis,
No proinflammatory markers
Extrinsic - via TNF receptor or Fas
Intrinsic (mitochondrial) - via release of pro-apoptotic molecules into cytoplasm via loss of Bcl-2 anti-apoptotic gene
PHYSIOLOGICAL
- during embryogenesis
- hormone-dependent involution
- elimination of harmful self-reactive lymphocytes
- induced by cytotoxic T-cells
PATHOLOGICAL
- in tumours
- atrophy after obstruction
- cytotoxic drugs and radiation
- cell injury in viral disease
B-cell lymphoma 2 gene
Family of oncogenes
Can be anti-apoptotic or pro-apoptotic
Live in mitochondria
Necrosis
Cell death in living tissues by enzymatic degradation
See - loss of membrane integrity, enzymatic digestion of cells, host reaction
Within 4-12h of insult
Gangrene is black necrotic tissue - wet (colliquative necrosis), dry (coagulative necrosis), gas (exotocin-producing clostridial species (usually C perfringens))
Patterns of necrosis determined by blood supply to organs
eg necrosis of striated tissue is rhabdomyolysis
Types of necrosis
COLLIQUATIVE = liquefaction
- due to action of tissue digestive enzymes
- mainly in CNS, kidney, pancreas
- caused by focal bacterial/fungal infections
COAGULATIVE
- hypoxic cell injury
- due to protein denaturation
- intracellular organelles disrupted, but shape of tissues maintained as proteins stick together
CASEOUS
- features between the two above
- tissues semi-solid/liquid
FIBRINOID
- due to immune-mediated vascular injury causing fibrin-like protein deposits in arterial walls
FAT
- due to lipase, tissues become chalky
- seen in breast, pancreas, omentum, skin
What mediates cell injury
Lipids
- TAG causing steatosis eg heart, liver, kidney
- cholesterol causing atherosclerosis, xanthoma, foamy macrophages
Proteins
Hyaline changes
Glycogen
Pigments
- lipofuscin (end product of free radical injury, brown), melanin (from tyrosine), haemosiderin
Cellular ageing process
Replicative senescence = cells have limited capacity for replication. After fixed no of divisions all cells arrest in terminally non-dividing state, caused by telomere shortening
Also influenced by free radical oxidate damage and genetic influence
Telomerase
Specialised enzyme made of RNA and protein, uses RNA as template for adding nucleotides to end of chromosomes
- maintains length of telomere
- prevents replicative sequence
- activity HIGH in germ cells, LOW in stem cells, absent in somatic cells, reactivated in cancer cells
Physiological response to injury
Immobility/rest
Loss of appetite
Catabolism
Minor - increased HR/RR/temp/WBC
Major - SIRS/hypermetabolism/catabolism/multiorgan dysfunction
Immunological and neuroendocrine responses
Ebb and flow phases in response to injury
Ebb = shock
- begins immediately from injury, lasts 24-48hrs
- hypovolaemia, reduced CO, decreased basal metabolic rate, hypothermia, lactic acidosis
- catecholamines, cortisol, aldosterone are main hormones
- functions to conserve circulating volume and energy stores
Flow
- hypermetabolic, like SIRS
- initial catabolic phase 3-4 days to mobilise energy stores (weight loss, urinary nitrogen excretion), later anabolic phase lasting weeks
- tissue oedema, vasodilating, increased CO, hypermetabolism, increased temp, leukocytosis, increased oxygen consumption, increased gluconeogenesis
Immunological response in injury
From proinflammatory to compensatory anti-inflammatory response CARS
Proinflammatory - mediated by innate immune system (interacts with adaptive immune system T and B cells) for pro-inflammatory cytokines (IL1, TNF, IL6, IL8) in first 24hrs, pyrexia due to action on hypothalamus, proteolysis in skeletal muscles, acute phase protein production in liver
- response followed by increased cytokine antagonists leading to CARS
Neuroendocrine response to injury
Biphasic:
ACUTE
- active secretion of pituitary and counter-regulatory hormones glucagon, cortisol, adrenaline
CHRONIC
- hypothalamic suppression and low serum levels of target hormone organs, so wasting
eg increased CRH from hypothalamus, increased secretion of ACTH from anterior pituitary, release of cortisol from adrenals
Counter-regulatory hormones to reduce insulin, increase metabolism, hepatic gluconeogenesis, adipocyte lipolysis, skeletal muscle protein catabolism, inactivate peripheral thyroid hormone, reduce testosterone, increase prolactin and GH
Energy expenditure in trauma
Increased by 25%
- central thermo-dysregulation
- increased sympathetic activity
- abnormalities in wound circulation - ischaemic areas produce lactate -> metabolised in Cori’s cycle, hyperaemic areas cause increased CO
- increased protein turnover
Protein metabolism in response to injury
SKELETAL MUSCLE
Protein degradation in peripheral tissues (skin, skeletal muscle, adipose tissue)
Muscle catabolism cannot be inhibited fully, so turnover rate 1-2%/day
HEPATIC
Liver protein turnover rate 20%/day - 1/2 for renewal of structural protein and 1/2 for synthesis of export protein
- during inflammation hepatic synthesis of acute phase proteins (fibrinogen, CRP), and serum albumin decreased due to transcapillary escape